http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109310634-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109310634-B |
| titleOfInvention | Nanoliposomes for continuous delivery of tacrolimus for the treatment of anterior segment eye diseases |
| abstract | According to the present disclosure, there is provided the use of nanoliposomes in the preparation of a medicament for preventing and/or treating anterior segment eye diseases. The nanoliposome comprises at least one lipid bilayer formed of a plurality of unsaturated and/or saturated lipids, and the lipid bilayer encapsulates a hydrophobic drug comprising tacrolimus, wherein the hydrophobic The weight ratio of drug to the plurality of unsaturated and/or saturated lipids is up to 0.2. The present disclosure also provides such nanoliposomes and methods of preventing and/or treating anterior segment eye diseases based on the nanoliposomes. |
| priorityDate | 2016-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.